TO THE EDITOR: Sirtuin-3 (SIRT3), one of the Sirtuin's family members, functions as a critical mitochondrial deacetylase, which implicates in a series of metabolic processes. However, the molecular mechanism of SIRT3 remains unclear. Recently, the article by Porter et al. (3), published in the American Journal of Physiology-Heart and Circulatory Physiology, manifested that SIRT3 knockdown cells were more vulnerable to simulated ischemia-reperfusion injury. The results hinted that decreased SIRT3 might increase the susceptibility of cardiac-derived cells and adult hearts to ischemia-reperfusion injury. It suggested that SIRT3 deficiency was a good potential biomarker associated with ischemia-reperfusion injury.
chondrial SIRT3 expression was associated with poor outcome in breast cancer.
Taken together, these findings suggested that SIRT3 played an important role in the progress of cancer, cardiovascular disease and pulmonary arterial hypertension. We read with interest and enjoyed reading the article by Porter GA et al. and thought that decreased SIRT3 expression was a good potential biomarker associated with diseases. 
